id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-5323-0002,FDA,FDA-2023-N-5323,"Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications; Correction",Notice,Correction,2024-03-14T04:00:00Z,2024,3,2024-03-14T04:00:00Z,,2024-03-14T14:18:32Z,2024-05426,0,0,090000648647b5fa
FDA-2023-N-5323-0001,FDA,FDA-2023-N-5323,"Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications",Notice,Withdrawal,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,,2023-12-18T14:31:47Z,2023-27661,0,0,0900006486343a3b